Considering that tumor cells may express VEGF receptors [19,20,21], and that even non-receptor mediated SLT-VEGF toxicity might be cell-specific, we explored the sensitivity of Line IV Cl 1 melanoma cells to SLT-VEGF in vitro. The gene discussed is VEGFA; the disease is melanoma.